OpenScience.ink

1 month ago • Gastro hep advances

Glucagon-Like Peptide-1 Receptor Drugs and Their Role in Inflammatory Bowel DiseaseGlucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Narrative Review.

📖 Top 50% Journal

1 month ago • The journal of allergy and clinical immunology. Global

📖 Top 20% Journal

yesterday • Case reports in neurology

Sudden Nerve Damage Linked to Semaglutide-Related Stomach Problems: A Case ReportAcute Nutritional Axonal Neuropathy in the Setting of Semaglutide-Associated Gastrointestinal Intolerance: A Case Report.

Case Reports

5 days ago • Biologie aujourd'hui

A History of GLP-1 and GIP Hormones: From Body Signals to Versatile Medicines[An historical overview of GLP-1/GIP incretins. From hormone to "swiss-army knife" medications].

Historical Article

1 week ago • Case reports in neurology

Nerve Weakness Causing Foot Drop Linked to Leg Crossing After Weight Loss with TirzepatideWeight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss.

Case Reports

5 days ago • Endocrine

Timing of GLP-1 receptor agonist treatment in pregnancy-related high blood pressure disordersHypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.

Systematic Review

2 days ago • Internal medicine (Tokyo, Japan)

Unusual Anorexia Nervosa After Weight-Loss Surgery and Diabetes Medication in a Patient with Severe Obesity and Type 2 DiabetesAtypical Anorexia Nervosa Developed in a Patient with Severe Obesity and Type 2 Diabetes Following Sleeve Gastrectomy and Postoperative Treatment with Semaglutide and Tirzepatide.

Article

4 days ago • Indian journal of endocrinology and metabolism

Whey protein before breakfast may reduce blood sugar spikes and increase insulin response in type 2 diabetesEffect of Pre-breakfast Whey Protein Supplement on Post-breakfast Glycaemic Excursion and Insulinotropic Response in Type 2 Diabetes Mellitus.

📖 Top 50% JournalArticle

4 days ago • Neurotrauma reports

Exenatide's effects on cell energy problems after spinal cord injuryEffects of GLP-1 Receptor Agonist Exenatide on Mitochondrial Dysfunction After Spinal Cord Injury.

📖 Top 30% JournalArticle

1 week ago • Medicine

Semaglutide's effects on fatty liver disease and liver inflammation linked to metabolism: Review and analysis of placebo-controlled trialsTherapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment.

📖 Top 50% Journal

1 week ago • Cardiology in review

Different Effects of Two Diabetes Drugs Added After Heart Surgery on Patient OutcomesDifferential Effects of GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-on Therapy on Outcomes Following Cardiac Surgery: A Propensity Score-Matched Analysis.

📖 Top 50% Journal

2 weeks ago • Indian journal of orthopaedics

Possible Uses of Glucagon-Like Peptide-1 Receptor Drugs in Bone and Joint CareGlucagon-Like Peptide-1 Receptor Agonists in Orthopedics: A Scoping Review of Emerging Applications.

📖 Top 50% Journal

2 weeks ago • Archives of endocrinology and metabolism

Effects and safety of GLP-1 receptor drugs in kidney transplant patients with diabetes after transplantGLP-1 receptor agonists in kidney transplant recipients with post-transplant diabetes: efficacy and safety outcomes from a retrospective cohort study.

📖 Top 50% Journal

2 weeks ago • Clinical lymphoma, myeloma & leukemia

Link Between Diabetes Treatments Targeting GLP-1 Receptors and Risk of Blood CancersAssociation of GLP1-Receptor Agonists With Risk of Hematologic Malignancies in People With Diabetes.

📖 Top 50% Journal

3 weeks ago • Journal of diabetes and metabolic disorders

Effects and safety of GLP-1 drugs on heart and metabolism health in overweight or obese Chinese adultsEfficacy and safety of GLP-1RA on cardio-metabolic outcomes in overweight or obese Chinese adults: a systematic review and meta-analysis.

📖 Top 50% Journal

3 weeks ago • Case reports in gastroenterology

Blocking a Specific Intestinal Bile Acid Transporter to Treat Severe Constipation Caused by Tirzepatide: A Case ReportTargeted Ileal Bile Acid Transporter Inhibition as Rescue Therapy for Tirzepatide-Induced Severe Constipation: A Case Report.

3 weeks ago • Military medicine

Use Patterns of GLP-1 Medicines for Weight Management in Active Duty Service Members from 2021 to 2025Patterns of Use for GLP-1 Receptor Agonists in a Weight Management Cohort: A Military Health System Database Analysis of Active Duty Service Members From 2021 to 2025.

📖 Top 50% Journal

3 weeks ago • The Journal of international medical research

Glucagon-like peptide-1 receptor agonists and their effects on body weight and kidney protein levels in people with and without type 2 diabetesEffect of glucagon-like peptide-1 receptor agonists on body weight and urinary albumin-to-creatinine ratio in patients with and without type 2 diabetes: A systematic review and meta-analysis.

📖 Top 50% Journal

4 weeks ago • Cutis

How GLP-1 Receptor Agonists May Affect Hidradenitis Suppurativa: A Complete ReviewThe Effect of GLP-1 Receptor Agonists on Hidradenitis Suppurativa: A Comprehensive Systematic Review.

1 month ago • Endocrine, metabolic & immune disorders drug targets

Semaglutide's possible impact on muscle and bone health linked to GLP-1 receptor levelsSemaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression.

📖 Top 50% Journal

1 month ago • Journal of neurological surgery. Part B, Skull base

Lowering Brain Fluid Leaks in Idiopathic Intracranial Hypertension Using GLP-1 Receptor AgonistsReduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use.

📖 Top 50% Journal

2 days ago • The Journal of the Association of Physicians of India

Glucagon-based Treatments and Vision Loss Risks in India: Weighing Benefits and CautionsGlucagon Agonist Therapies and Vision Loss: Balancing Promise with Prudence in India.

Article

5 days ago • Biologie aujourd'hui

Changes in How Doctors Manage Obesity[Changes in obesity management: The clinician's perspective].

English Abstract

3 weeks ago • Innere Medizin (Heidelberg, Germany)

Recent Advances in Hormone and Diabetes Research[New developments in endocrinology/diabetology].

3 weeks ago • A&A practice

Severe Lactic Acidosis and High Blood Sugar After Surgery Improving with Thiamine in a Patient Using Semaglutide and Following a Restrictive DietSevere Perioperative Lactic Acidosis and Hyperglycemia Responsive to Thiamine in a Patient With Prior Semaglutide Use and Restrictive Dieting: A Case Report.

5 days ago • Cureus

Weight Regain After Stopping Weight Loss Medications: A Review and Combined AnalysisPost-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis.

Article

6 days ago • Journal of clinical pharmacology

First Human Study of a Long-Lasting GLP-1 Drug in Overweight or Obese Adults Without Type 2 DiabetesFirst-in-Human Study of a Long-Acting GLP-1 Receptor Agonist (TE-8105) in Overweight or Obese Adults Without Type 2 Diabetes Mellitus.

Clinical Trial, Phase I

3 weeks ago • bioRxiv : the preprint server for biology

Separate processing of body signals in the brain's area that controls vomiting and blood pressureFunctional segregation of body-brain signals in the area postrema.

3 weeks ago • Journal of virology

Glucagon-like peptide-1 receptor agonist may prevent lung scarring after COVID-19 in people with type 2 diabetesGlucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes.

4 days ago • Research square

Mapping Communication Routes in the GLP-1 Receptor Using Molecular Simulations and Network AnalysisUncovering Allosteric Signaling Pathways of GLP-1R via Molecular Dynamics and Network Theory.

Preprint

← prevpage 11 of 15next →

GLP-1 Therapies Research Papers